Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2016

  • ID: 3635550
  • Company Profile
  • 55 pages
  • Global Markets Direct
  • Sunovion
1 of 4
Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2016

Summary

The report ‘Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2016’, provides an overview of the Sunovion Pharmaceuticals Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sunovion Pharmaceuticals Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Sunovion Pharmaceuticals Inc.
- The report provides overview of Sunovion Pharmaceuticals Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Sunovion Pharmaceuticals Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Sunovion Pharmaceuticals Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Sunovion Pharmaceuticals Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Sunovion Pharmaceuticals Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Sunovion Pharmaceuticals Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Sunovion Pharmaceuticals Inc. Snapshot

Sunovion Pharmaceuticals Inc. Overview

Key Information

Key Facts

Sunovion Pharmaceuticals Inc. - Research and Development Overview

Key Therapeutic Areas

Sunovion Pharmaceuticals Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Sunovion Pharmaceuticals Inc. - Pipeline Products Glance

Sunovion Pharmaceuticals Inc. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Sunovion Pharmaceuticals Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Sunovion Pharmaceuticals Inc. - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Sunovion Pharmaceuticals Inc. - Drug Profiles

eslicarbazepine acetate

Product Description

Mechanism of Action

R&D Progress

dasotraline

Product Description

Mechanism of Action

R&D Progress

glycopyrrolate

Product Description

Mechanism of Action

R&D Progress

DSP-2230

Product Description

Mechanism of Action

R&D Progress

DSP-3748

Product Description

Mechanism of Action

R&D Progress

SEP-363856

Product Description

Mechanism of Action

R&D Progress

SEP-360

Product Description

Mechanism of Action

R&D Progress

SEP-39

Product Description

Mechanism of Action

R&D Progress

Small Molecule 1 for Neuropsychiatric Disorders

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Neuropsychiatric Disorders

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit D-amino acid oxidase for Neuropathic Pain, Inflammatory Pain and Memory Impairment

Product Description

Mechanism of Action

R&D Progress

EP-103

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Central Nervous System Disorders

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Modulate GPCR and Ion Channel for Psychiatric Disorders

Product Description

Mechanism of Action

R&D Progress

Sunovion Pharmaceuticals Inc. - Pipeline Analysis

Sunovion Pharmaceuticals Inc. - Pipeline Products by Target

Sunovion Pharmaceuticals Inc. - Pipeline Products by Route of Administration

Sunovion Pharmaceuticals Inc. - Pipeline Products by Molecule Type

Sunovion Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action

Sunovion Pharmaceuticals Inc. - Recent Pipeline Updates

Sunovion Pharmaceuticals Inc. - Dormant Projects

Sunovion Pharmaceuticals Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

dasotraline

DSP-1053

DSP-8658

SEP-228432

tecastemizole

Sunovion Pharmaceuticals Inc. - Locations and Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Sunovion Pharmaceuticals Inc., Key Information

Sunovion Pharmaceuticals Inc., Key Facts

Sunovion Pharmaceuticals Inc. - Pipeline by Indication, 2016

Sunovion Pharmaceuticals Inc. - Pipeline by Stage of Development, 2016

Sunovion Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2016

Sunovion Pharmaceuticals Inc. - Partnered Products in Pipeline, 2016

Sunovion Pharmaceuticals Inc. - Partnered Products/ Combination Treatment Modalities, 2016

Sunovion Pharmaceuticals Inc. - Pre-Registration, 2016

Sunovion Pharmaceuticals Inc. - Phase III, 2016

Sunovion Pharmaceuticals Inc. - Phase II, 2016

Sunovion Pharmaceuticals Inc. - Phase I, 2016

Sunovion Pharmaceuticals Inc. - IND/CTA Filed, 2016

Sunovion Pharmaceuticals Inc. - Preclinical, 2016

Sunovion Pharmaceuticals Inc. - Discovery, 2016

Sunovion Pharmaceuticals Inc. - Pipeline by Target, 2016

Sunovion Pharmaceuticals Inc. - Pipeline by Route of Administration, 2016

Sunovion Pharmaceuticals Inc. - Pipeline by Molecule Type, 2016

Sunovion Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2016

Sunovion Pharmaceuticals Inc. - Recent Pipeline Updates, 2016

Sunovion Pharmaceuticals Inc. - Dormant Developmental Projects,2016

Sunovion Pharmaceuticals Inc. - Discontinued Pipeline Products, 2016

Sunovion Pharmaceuticals Inc., Other Locations

Sunovion Pharmaceuticals Inc., Subsidiaries

List of Figures

Sunovion Pharmaceuticals Inc. - Pipeline by Top 10 Indication, 2016

Sunovion Pharmaceuticals Inc. - Pipeline by Stage of Development, 2016

Sunovion Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2016

Sunovion Pharmaceuticals Inc. - Partnered Products in Pipeline, 2016

Sunovion Pharmaceuticals Inc. - Pipeline by Top 10 Target, 2016

Sunovion Pharmaceuticals Inc. - Pipeline by Route of Administration, 2016

Sunovion Pharmaceuticals Inc. - Pipeline by Molecule Type, 2016

Sunovion Pharmaceuticals Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll